{
  "retracted": false,
  "timestamp": 1467244800000,
  "updates": [
    {
      "timestamp": 1581714667310,
      "identifier": {
        "doi": "10.1038/ajg.2016.202"
      },
      "type": "erratum"
    }
  ],
  "identifier": {
    "doi": "10.1038/ajg.2016.108"
  },
  "publisher": "Ovid Technologies (Wolters Kluwer Health)",
  "title": "Corrigendum: Safety and Efficacy of Ombitasvir/Paritaprevir/Ritonavir Plus Dasabuvir With or Without Ribavirin in HCV-Infected Patients Taking Concomitant Acid-Reducing Agents"
}
